Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors: P1-argininal derivatives incorporating P3-P4 lactam sulfonamide moieties.

Source:http://linkedlifedata.com/resource/pubmed/id/8917639

J. Med. Chem. 1996 Nov 8 39 23 4531-6

Download in:

View as

General Info

PMID
8917639